Form 8-K - Current report:
SEC Accession No. 0001299933-13-001574
Filing Date
2013-08-29
Accepted
2013-08-29 17:24:10
Documents
3
Period of Report
2013-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_48395.htm 8-K 22697
2 EX-10.1 exhibit1.htm EX-10.1 71219
3 EX-10.2 exhibit2.htm EX-10.2 61619
  Complete submission text file 0001299933-13-001574.txt   157177
Mailing Address 777 OLD SAW MILL RIVER RD. TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER RD. TARRYTOWN NY 10591 914-606-3500
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51290 | Film No.: 131070119
SIC: 2834 Pharmaceutical Preparations